NEWM&A

Janus Henderson (JHG) Regulatory Approval for Take-Private Deal

Published on 6/22/2026

#JHG#M&A#take-private
Janus Henderson (JHG) Regulatory Approval for Take-Private Deal

AI Summary

Janus Henderson Group (JHG) has received the necessary regulatory approvals for its take-private deal with Trian Fund Management. Shareholders have voted in favor of the proposal, which is set to close on June 30, 2026, pending other conditions. The revised agreement offers $52 per share in cash for shareholders, up from a previous offer of $49, representing a 25% premium based on the share price from October 24, 2025. The transaction will result in Janus Henderson operating as a privately held company with its shares delisted from the NYSE.

Source: Read original article (opens in new tab)

Related News

AbbVie (ABBV) Acquires Apogee for $10.9 Billion Eczema Drug
M&A

AbbVie (ABBV) Acquires Apogee for $10.9 Billion Eczema Drug

Jun 22

AbbVie (ABBV) Acquires Apogee for $10.9 Billion in Immunology Deal
M&A

AbbVie (ABBV) Acquires Apogee for $10.9 Billion in Immunology Deal

Jun 22

Citi (C) Appoints Rajeev Garg as UAE Wealth Head
M&A

Citi (C) Appoints Rajeev Garg as UAE Wealth Head

Jun 22

Ferrari (RACE) Denies Conditional Purchase Tied to Luce EV
M&A

Ferrari (RACE) Denies Conditional Purchase Tied to Luce EV

Jun 22